MSTN and neoplasm: In this regard, treatment with anti-cytokine antibodies, cytokine receptor agonists, or myostatin (Mstn) blockade using activin IIB receptor (actRIIB) antagonists reduced muscle wasting and improved physical performance in the tumor-bearing experimental cachexia model8, 11, 12, 13.